SAN JOSE, Calif., Feb. 9 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, today announced its plans to present at the Roth 21st Annual OC Growth Stock Conference, to be held February 16 - 18, 2009, at The Ritz Carlton in Dana Point, California. The management speaker will be Peter Osborne, Chief Financial Officer and Vice President of Finance and Administration.
VNUS' presentation is currently scheduled for 9:30 a.m. PT on Tuesday, February 17, and will be webcast on the corporate website at http://ir.vnus.com/events.cfm.
About VNUS Medical Technologies, Inc.
VNUS is a leading provider of medical devices for the minimally invasive treatment of venous reflux, a progressive condition caused by incompetent vein valves in the leg. VNUS sells the Closure system, which consists of a proprietary radiofrequency (RF) generator and proprietary disposable endovenous catheters and devices to treat diseased veins through the application of temperature-controlled RF energy. For more information, please visit the corporate website at http://www.vnus.com.
|SOURCE VNUS Medical Technologies, Inc.|
Copyright©2009 PR Newswire.
All rights reserved